Targeted Gene Delivery to Selected Liver Segments Via Isolated Hepatic Perfusion

Journal of Surgical Research

Volumn 160, Issue 1, 2010, Pages 47-51

  Kinoshita, Hiroyasu ^a   Watanabe, Atsushi ^a   Hisayasu, Sanae ^a   Suzuki, Satoru ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

adenovirus vector; chemotherapy; gene targeting; gene therapy; hepatic lobe; isolating hepatic perfusion; rat

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; HISTOCHEMISTRY; INFERIOR CAVA VEIN; LIVER PERFUSION; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; EOSINE YELLOWISH-(YS); FEMALE; GALACTOSIDES; GENE THERAPY; GENETIC VECTORS; HEMATOXYLIN; INDOLES; LIVER; LIVER DISEASES; PERFUSION; RATS; RATS, WISTAR; TRANSGENES;

EID: 77950201377     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.01.030     Document Type: Article

References (15)

1. Nguyen T.H., and Ferry N. Liver gene therapy: Advances and hurdles. Gene Ther 11 (2004) S76
2. Raper S.E., Chirmule N., Lee F.S., et al. Fatal systemic inflammatory response syndrome in ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab 80 (2003) 148
3. Kramer M.G., Barajas M., Razquin N., et al. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther 7 (2003) 375
4. Rothbarth J., Tollenaar R.A., Schellens J.H., et al. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: Recent trends and perspectives. Eur J Cancer 40 (2004) 1812
5. van Etten B., Eggermont A.M., van Tiel S.T., et al. Gene therapy in in vivo isolated perfusion models. Curr Gene Ther 5 (2005) 195
6. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193
7. Kanegae Y., Makimura M., and Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47 (1994) 157
8. Ohashi K., Nakai H., Couto L.B., et al. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver. Hum Gene Ther 16 (2005) 299
9. Drazan K.E., Csete M.E., Da She X., et al. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J Surg Res 59 (1995) 299
10. Futagawa Y., Okamoto T., Ohashi T., et al. Efficiency of adenovirus-mediated gene transfer into hepatocytes by liver asanguineous perfusion method. Res Exp Med 199 (2000) 263
11. de Roos W.K., Fallaux F.J., Marinelli A.W., et al. Isolated-organ perfusion for local gene delivery: Efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4 (1997) 55
12. Scholl B., Gervaz P., Martinet O., et al. Adenovirus-mediated gene transfer into selected liver segments using a vascular exclusion technique. Eur Surg Res 33 (2001) 348
13. Liu Q., and Muruve D.A. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 10 (2003) 935
14. Elkon K.B., Liu C.C., Gall J.G., et al. Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci 94 (1997) 9814
15. Peng Y., Trevejo J., Zhou J., et al. Inhibition of tumor necrosis factor α by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung. J Virol 73 (1999) 5098